Zensun Enterprises Limited (0185.HK) operates as an investment holding company primarily engaged in property development, property investment, project management and sales services, hotel operations, securities trading and investment. The company develops and markets high-rise residential buildings, low-rise apartments, and commercial properties through its Property Development in the People's Republic of China (PRC) segment; provides initial project management and sales services in the PRC; manages hotel operations in the PRC; invests in and manages real estate via American Housing REIT, Inc. (AHR) and Global Medical REIT, Inc. (GMR) in the United States; pursues property investments in regions including Hong Kong and Singapore outside AHR; and conducts securities trading and investment activities. Zensun Enterprises maintains operations across the PRC, Hong Kong, the United States, and Singapore, targeting residential, commercial, and healthcare-related real estate markets with customers encompassing individual homebuyers, institutional investors, and healthcare tenants. Founded in 1995 and headquartered at 24/F, Wyndham Place, 40-44 Wyndham Street, Central, Hong Kong, the company changed its name from ZH International Holdings Limited to Zensun Enterprises Limited in July 2019 to strengthen brand identity. Recent developments include the renewal of the 2024 Master Services Agreement with Zensun Development on 30 October 2023 to govern ongoing connected transactions; suspension of trading for its 2024 Senior Notes on 24 November 2023 followed by full redemption post-31 December 2023; and approval of annual caps for transactions under the 2024-2026 Master Services Agreement at an extraordinary general meeting in late 2023.